BioNTech SE

Astrazeneca says that the initial delivery volumes of the Covid vaccine in the EU are insufficient

Studies of South African coronavirus strains raise concerns about immune response

Myths of the coronavirus vaccine detonated by experts

Europeans clash with Pfizer and BioNTech over Covid-19 vaccine deliveries

Pfizer-BioNTech vaccine likely to be effective against the UK variant

Challenges and problems in vaccine strategy

UK hospitals use blockchain to monitor the temperature of the coronavirus vaccine

Argentina is a testing ground for Moscow’s Global Vaccine Drive

Pfizer will temporarily reduce deliveries of Covid vaccines to Europe

Recipients cannot let down their guard, says Dr. Scott Gottlieb

The Johnson & Johnson Covid-19 vaccine could change the course of the pandemic. Investors will soon know if it works.

AstraZeneca’s may be distributed in the EU in mid-February